Oncology Institute (TOIIW) Non-Current Assets (2019 - 2026)

Oncology Institute (TOIIW) has 8 years of Non-Current Assets data on file, last reported at $51.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 10.17% year-over-year to $51.4 million; the trailing twelve-month figure through Mar 2026 stood at $211.8 million (down 13.06% YoY), and the FY2025 full-year result was $51.9 million, down 13.91% from the prior year.
• Non-Current Assets for Q1 2026 stood at $51.4 million, down from $51.9 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $140.2 million in Q3 2022 and bottomed at $51.4 million in Q1 2026.
• The 5-year median for Non-Current Assets is $63.4 million (2024), against an average of $76.9 million.
• Peak annual rise in Non-Current Assets reached 165.77% in 2022, while the deepest fall reached 71.05% in 2022.
• A 5-year view of Non-Current Assets shows it stood at $131.2 million in 2022, then slumped by 49.91% to $65.7 million in 2023, then dropped by 8.29% to $60.3 million in 2024, then decreased by 13.91% to $51.9 million in 2025, then decreased by 1.04% to $51.4 million in 2026.
• The last three Non-Current Assets figures came in at $51.4 million (Q1 2026), $51.9 million (Q4 2025), and $53.5 million (Q3 2025), per Business Quant data.

Peer Comparison